Edwards Lifesciences earnings were $4.2B for the trailing 12 months ending Dec 31, 2024, with 202.2% growth year over year. The latest EW earnings report on Dec 31, 2024 announced Q4 2024 earnings of $385.6M, down 87.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, EW reported annual earnings of $4.2B, with 197.7% growth.
EW past earnings growth
How has EW's earnings growth performed historically?
Edwards Lifesciences Earnings Reports & History FAQ
What were Edwards Lifesciences's earnings last quarter?
On EW's earnings call on Invalid Date, Edwards Lifesciences (NYSE: EW) reported Q4 2024 earnings per share (EPS) of $0.67, up 9.84% year over year. Total EW earnings for the quarter were $385.60 million. In the same quarter last year, Edwards Lifesciences's earnings per share (EPS) was $0.61.
Is Edwards Lifesciences profitable or losing money?
As of the last Edwards Lifesciences earnings report, Edwards Lifesciences is currently profitable. Edwards Lifesciences's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $4.17 billion, a 197.68% increase year over year.
What was EW's earnings growth in the past year?
As of Edwards Lifesciences's earnings date in Invalid Date, Edwards Lifesciences's earnings has grown 202.16% year over year. This is 154.96 percentage points higher than the US Medical Devices industry earnings growth rate of 47.2%. EW earnings in the past year totalled $4.17 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.